Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTD vs VCD as Induction Treatment in Newly Diagnosed Multiple Myeloma
NCT01971658Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Oct 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide, cyclophosphamide in multiple myeloma (MM), sponsored by CHU de Nantes. Started Oct 2013; status: completed.
02
Drugs
thalidomidecyclophosphamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01971658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01971658.